VVT MED INC. — M&A Activity 2025

Mar 28, 2025

FORM 51-102F3

MATERIAL CHANGE REPORT

1. Name and Address of Company:
   DXI Capital Corp.
   999 Canada Place, Suite 404
   Vancouver, BC V6C 3E2
   (the "Company")

2. Date of Material Change:
   March 24, 2025

3. Press Release:
   A press release was disseminated on March 25, 2025 and was subsequently filed on SEDAR+.

4. Summary of Material Change:
   The Company announced that it had received conditional approval from the TSX Venture Exchange for its reverse takeover transaction with V.V.T. Med Ltd. ("VVT") and Exiteam Acquisition Corp. ("EAC"), together with VVT and DXI, the "Parties"), previously announced in its press releases dated November 28, 2024, October 1, 2024 and November 24, 2023 (the "Proposed Transaction"). Completion of the Proposed Transaction is subject to a number of conditions including, but not limited to receipt of all requisite regulatory, stock exchange, court or governmental approvals, authorizations and consents and the conditions set out in the definitive agreement between the Parties dated September 30, 2024. Assuming all conditions are satisfied, the Parties anticipate closing of the Proposed Transaction within the next 45 days.

5. Full Description of Material Change:
   See Schedule "A".

6. Reliance on Subsection 7.1(2) of the National Instrument 51-102 Continuous Disclosure Obligations:
   Not applicable.

7. Omitted Information:
   Not applicable.

8. Executive Officer Knowledgeable of Material Change:
   Sean Hodgins, CFO
   Telephone: (778) 318-1514

9. Date of Report:
   March 28, 2025